IVC Wealth Advisors LLC Takes $873,000 Position in Ralliant Corporation $RAL

IVC Wealth Advisors LLC acquired a new stake in shares of Ralliant Corporation (NYSE:RAL) during the 3rd quarter, Holdings Channel reports. The fund acquired 19,968 shares of the company’s stock, valued at approximately $873,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of RAL. Farmers & Merchants Investments Inc. acquired a new position in Ralliant in the 2nd quarter valued at $662,000. GAMMA Investing LLC purchased a new stake in shares of Ralliant in the second quarter valued at $56,000. Alpha Omega Wealth Management LLC acquired a new position in Ralliant in the second quarter valued at $213,000. Public Employees Retirement System of Ohio acquired a new position in Ralliant in the second quarter valued at $1,799,000. Finally, TD Private Client Wealth LLC purchased a new position in Ralliant during the second quarter worth about $284,000.

Ralliant Stock Performance

Shares of NYSE:RAL opened at $52.26 on Friday. The business’s 50-day moving average price is $46.76. The stock has a market cap of $5.90 billion and a PE ratio of 41.15. Ralliant Corporation has a 1 year low of $40.70 and a 1 year high of $55.08. The company has a quick ratio of 1.03, a current ratio of 1.49 and a debt-to-equity ratio of 0.39.

Ralliant (NYSE:RAL) last posted its quarterly earnings results on Wednesday, November 5th. The company reported $0.60 EPS for the quarter, beating the consensus estimate of $0.58 by $0.02. The business had revenue of $529.10 million during the quarter, compared to analysts’ expectations of $519.14 million. Ralliant has set its Q4 2025 guidance at 0.620-0.680 EPS.

Ralliant Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 23rd. Investors of record on Monday, December 8th will be issued a dividend of $0.05 per share. The ex-dividend date is Monday, December 8th. This represents a $0.20 annualized dividend and a dividend yield of 0.4%. Ralliant’s payout ratio is presently 15.75%.

Analyst Ratings Changes

Several analysts have commented on the company. Oppenheimer lifted their price target on Ralliant from $55.00 to $60.00 and gave the company an “outperform” rating in a report on Monday. Royal Bank Of Canada raised their target price on shares of Ralliant from $45.00 to $52.00 and gave the stock a “sector perform” rating in a research report on Friday, November 7th. Truist Financial began coverage on shares of Ralliant in a research report on Friday, December 12th. They set a “buy” rating and a $62.00 price target for the company. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Ralliant in a research note on Monday. Finally, Morgan Stanley began coverage on shares of Ralliant in a report on Tuesday, September 2nd. They issued an “overweight” rating and a $55.00 price target on the stock. Six analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $57.89.

Ralliant Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.